Potential suggested for investigational anti-HIV drug combination.

Reports that preliminary data suggest that the combination of the antiretroviral agents 1592U89 and 141W94 may be able to treat HIV infection, according to a study presented at the 1997 Conference on Retroviruses and Opportunistic Infections held in Washington D.C. Background on the study.